Home > Balance Sheet > MANKIND PHARMA

MANKIND PHARMA
Capital Work in Progress

    Back to Balance Sheet
MANKIND PHARMA is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
Best Quarterly Growth Large Cap Stocks
COMMUNITY POLL
for MANKIND PHARMA
Please provide your vote to see the results

MANKIND PHARMA Last 5 Year Capital Work in Progress History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
Capital Work in Progress ₹207 Cr₹493 Cr₹670 Cr₹372 Cr₹313 Cr

What is the latest Capital Work in Progress ratio of MANKIND PHARMA ?

The latest Capital Work in Progress ratio of MANKIND PHARMA is ₹207 Cr based on Mar2024 Consolidated results.
Year Capital Work in Progress
Mar2024₹207 Cr
Mar2023₹493 Cr
Mar2022₹670 Cr
Mar2021₹372 Cr
Mar2020₹313 Cr

How is Capital Work in Progress of MANKIND PHARMA Trending?

Years Capital Work in Progress % Change
Mar2024 ₹207 Cr
-58.01
Mar2023 ₹493 Cr
-26.38
Mar2022 ₹670 Cr
80.26
Mar2021 ₹372 Cr
18.63
Mar2020 ₹313 Cr -

Compare Capital Work in Progress of peers of MANKIND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MANKIND PHARMA ₹110,224.0 Cr -11.2% -2.3% 33.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹424,382.0 Cr -5.8% -3.2% 35.1% Stock Analytics
DIVIS LABORATORIES ₹159,224.0 Cr -2.8% -3.6% 44.7% Stock Analytics
CIPLA ₹116,943.0 Cr -3.9% -0.5% 13.9% Stock Analytics
DR REDDYS LABORATORIES ₹111,588.0 Cr -1.2% 7.1% 17.8% Stock Analytics
ZYDUS LIFESCIENCES ₹100,704.0 Cr -2.7% -0.1% 40.9% Stock Analytics


MANKIND PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
MANKIND PHARMA

-11.2%

-2.3%

33.6%

SENSEX

-2.1%

-6.4%

7%


You may also like the below Video Courses